H. Lundbeck AS - Company Profile
Powered by 
All the sales intelligence you need on H. Lundbeck AS in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how H. Lundbeck AS fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with H. Lundbeck AS.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, is a specialty pharmaceutical company, which discovers, develops, produces, and markets pharmaceuticals for the treatment of diseases of the central nervous system (CNS). Focus on R&D activities, revenue growth, global presence, and a strategic brand portfolio are its strengths even as high financial leverage could be a major cause for concern to the company. Lundbeck could benefit from the market potential for Parkinson's disease, regulatory approvals, and contract and agreements. However, intense competition, uncertain R&D outcomes, and stringent government regulations could hinder the company's growth.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer